In accordance, treatment of ALS mice with the c-Kit inhibitor masitinib, which has recognized anti-inflammatory and neuroprotective effects in ALS, significantly reduced MC number and trafficking as well as the microvascular pathology in ALS mice. This evidence concerns the gene KIT and amyotrophic lateral sclerosis.